IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5

Antaki, Nabil; Bibert, Stéphanie; Kebbewar, Kamel; Asaad, Fouad; Baroudi, Osama; Alideeb, Sawsan; Hadad, Milad; Abboud, Dirar; Sabah, Houda; Bochud, Pierre-Yves; Negro, Francesco

doi:10.1136/gutjnl-2012-302019

Scientific article

English

IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5

ContributorsAntaki, Nabil; Bibert, Stéphanie; Kebbewar, Kamel; Asaad, Fouad; Baroudi, Osama; Alideeb, Sawsan; Hadad, Milad; Abboud, Dirar; Sabah, Houda; Bochud, Pierre-Yves; Negro, Francesco

Published inGut, vol. 61, no. 11, p. 1640-1641

Publication date2012

Keywords

Antiviral Agents/therapeutic use
Female
Hepacivirus/genetics
Hepatitis C, Chronic/drug therapy
Humans
Interleukins/genetics
Male
Polymorphism, Single Nucleotide

Affiliation entities

Faculté de médecine / Section de médecine fondamentale / Département de pathologie et immunologie

Research groups

Etudes et traitement de l'hépatite C et B (554)

Citation (ISO format)

ANTAKI, Nabil et al. IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5. In: Gut, 2012, vol. 61, n° 11, p. 1640–1641. doi: 10.1136/gutjnl-2012-302019

Article (Published version)

Identifiers

PID : unige:27530
DOI : 10.1136/gutjnl-2012-302019
PMID : 22345656

Journal ISSN0017-5749

596views

0downloads

Creation25/03/2013 16:40:00

First validation25/03/2013 16:40:00

Update14/03/2023 20:09:06

Status update14/03/2023 20:09:06

Last indexation30/10/2024 09:17:05

Archive ouverte UNIGE

IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5

Technical informations